These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17872455)

  • 1. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
    Qin S; Liu T; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
    Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
    Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I.
    Yamato K; Tamasawa N; Murakami H; Matsui J; Tanabe J; Suda T; Yasujima M
    Diabetes Res Clin Pract; 2005 Aug; 69(2):124-8. PubMed ID: 16005361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
    Maejima T; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
    Biochem Biophys Res Commun; 2004 Nov; 324(2):835-9. PubMed ID: 15474503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
    Sviridov D; Pyle L; Fidge N
    Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic high-density lipoprotein secretion regulates the mobilization of cell-surface hepatic lipase.
    Chatterjee C; Young EK; Pussegoda KA; Twomey EE; Pandey NR; Sparks DL
    Biochemistry; 2009 Jun; 48(25):5994-6001. PubMed ID: 19425605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells.
    Zhang LH; Kamanna VS; Ganji SH; Xiong XM; Kashyap ML
    J Lipid Res; 2010 Aug; 51(8):2211-22. PubMed ID: 20371549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.
    Taskinen MR; Sullivan DR; Ehnholm C; Whiting M; Zannino D; Simes RJ; Keech AC; Barter PJ;
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):950-5. PubMed ID: 19325138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel compound 4010B-30 upregulates apolipoprotein A-I gene expression through activation of PPARγ in HepG2 cells.
    Du Y; Wang L; Si S; Yang Y; Hong B
    Atherosclerosis; 2015 Apr; 239(2):589-98. PubMed ID: 25734982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
    Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
    Singh JP; Kauffman R; Bensch W; Wang G; McClelland P; Bean J; Montrose C; Mantlo N; Wagle A
    Mol Pharmacol; 2005 Sep; 68(3):763-8. PubMed ID: 15933217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
    Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
    Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion.
    Pandey NR; Renwick J; Misquith A; Sokoll K; Sparks DL
    Biochemistry; 2008 Feb; 47(6):1579-87. PubMed ID: 18189424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
    Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
    Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
    Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
    Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency.
    Chroni A; Duka A; Kan HY; Liu T; Zannis VI
    Biochemistry; 2005 Nov; 44(43):14353-66. PubMed ID: 16245952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells.
    Jin FY; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):999-1006. PubMed ID: 9633943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2).
    Jin FY; Kamanna VS; Chuang MY; Morgan K; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1052-62. PubMed ID: 8696946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport.
    Jin FY; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2020-8. PubMed ID: 9351367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.